Due to the limited intrinsic healing ability of mature cartilage tissue, stem cell therapies offer the potential to restore cartilage lost due to trauma or arthritis. Mesenchymal stem cells (MSCs) are a promising cell source due to their ability to differentiate into various adult tissues under specific biochemical and physical cues. Current MSC chondrogenic differentiation strategies employ large pellets, however, we have previously developed a high-throughput technique to form small MSC aggregates (500-1,000 cells) that may reduce diffusion barriers while maintaining a multicellular structure that is analogous to cartilaginous condensations. The objective of this study was to examine the effects on chondrogenesis of incorporating chondroi...
International audienceUmbilical cord blood (UCB) is a promising alternative source of mesenchymal st...
Earlier, we have shown that the increased cartilage production in pellet co-cultures of chondrocytes...
Tissue engineering strategies represent exciting potential therapies to repair cartilage injuries; h...
Mesenchymal stem cells (MSCs) have been previously explored as a part of cell-based therapies for th...
Mesenchymal stem cells (MSCs) have been considered as a promising cell source for cartilage tissue r...
In this study we have tested the use of mesenchymal stromal/stem cell (MSC)– or chondrocyte (hch)–la...
Abstract Background Mesenchymal stem cells (MSCs) hold great promise for cartilage repair given thei...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
In the adult human, mesenchymal stem cells (MSCs) resident in bone marrow retain the capacity to pro...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
Mesenchymal stromal cells (MSCs) are currently used for cartilage cell therapy because of their well...
Cell therapy combined with biomaterial scaffolds is used to treat cartilage defects. We hypothesized...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
Abstract Background Microcarrier cultures which are useful for producing large cell numbers can act ...
International audienceUmbilical cord blood (UCB) is a promising alternative source of mesenchymal st...
Earlier, we have shown that the increased cartilage production in pellet co-cultures of chondrocytes...
Tissue engineering strategies represent exciting potential therapies to repair cartilage injuries; h...
Mesenchymal stem cells (MSCs) have been previously explored as a part of cell-based therapies for th...
Mesenchymal stem cells (MSCs) have been considered as a promising cell source for cartilage tissue r...
In this study we have tested the use of mesenchymal stromal/stem cell (MSC)– or chondrocyte (hch)–la...
Abstract Background Mesenchymal stem cells (MSCs) hold great promise for cartilage repair given thei...
Cell therapies for articular cartilage defects rely on expanded chondrocytes. Mesenchymal stem cells...
In the adult human, mesenchymal stem cells (MSCs) resident in bone marrow retain the capacity to pro...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
Mesenchymal stromal cells (MSCs) are currently used for cartilage cell therapy because of their well...
Cell therapy combined with biomaterial scaffolds is used to treat cartilage defects. We hypothesized...
Although bone marrow stromal cells (BMSCs) appear promising for cartilage repair, current clinical r...
Abstract Background Microcarrier cultures which are useful for producing large cell numbers can act ...
International audienceUmbilical cord blood (UCB) is a promising alternative source of mesenchymal st...
Earlier, we have shown that the increased cartilage production in pellet co-cultures of chondrocytes...
Tissue engineering strategies represent exciting potential therapies to repair cartilage injuries; h...